Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.

Nutritional approaches featuring reduced carbohydrates alongside elevated protein and fibre content trigger the release of ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

There is zero evidence that ​​semaglutides can increase the size of your crown jewels. What may happen is that as you lose ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...

Last and least, I look at the drug stocks and I can’t believe how awful they really are, with now Eli Lilly last joining the ...

This Is Us star Chrissy Metz reflects on her struggles with her body image and self-worth, and shares her thoughts on weight ...

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar ...